All lobbying filings

Chamber Hill Strategies

Chamber Hill Strategies filed a Q2 report for Marshall Bioresources on July 19, 2026, reporting $50,000 in lobbying income.

Lobbying for Marshall Bioresources · commercial animal breeder

As filed: CHAMBER HILL STRATEGIES for MARSHALL BIORESOURCES.

All filings by Chamber Hill Strategies · Everything Marshall Bioresources has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 19, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbyists on this filing 3

JENNIFER BELL

Previously held: Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)
JENNIFER HOLLAND

Previously held: Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06)
ZACHARY SCHULZ

Previously held: Legislative Correspondent, Sen. Charles Grassley (R-IA)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

S. 5048/HR 7248, the FDA Modernization Act; issues related to pre-clinical research

Bills named in this filing 2

S. 5048
Hydropower Licensing Affordability Act
H.R. 7248
FDA Modernization Act 3.0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.